Srn Advisors, LLC Abbott Laboratories Transaction History

Srn Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jun 14, 2024	SELL	$90.19 - $110.4 $589,932 - $722,126	-6,541 Closed	0 $0
Q3 2023 Jun 14, 2024	SELL	$95.53 - $114.62 $62,667 - $75,190	-656 Reduced 9.11%	6,541 $633 Million
Q2 2023 Jun 14, 2024	SELL	$100.78 - $112.29 $21,768 - $24,254	-216 Reduced 2.91%	7,197 $785 Million
Q1 2023 Jun 14, 2024	SELL	$96.86 - $114.01 $14,529 - $17,101	-150 Reduced 1.98%	7,413 $734 Million
Q4 2022 Jun 14, 2024	BUY	$95.06 - $111.52 $80,801 - $94,792	850 Added 12.66%	7,563 $830 Million
Q3 2022 Jun 14, 2024	SELL	$96.76 - $112.03 $126,658 - $146,647	-1,309 Reduced 16.32%	6,713 $650 Million
Q2 2022 Jun 14, 2024	SELL	$102.07 - $123.37 $137,182 - $165,809	-1,344 Reduced 14.35%	8,022 $872 Million
Q1 2022 Jun 14, 2024	BUY	$114.02 - $139.04 $15,962 - $19,465	140 Added 1.52%	9,366 $1.11 Billion
Q4 2021 Jun 14, 2024	BUY	$115.53 - $141.46 $1.07 Million - $1.31 Million	9,226 New	9,226 $1.3 Billion

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Srn Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Srn Advisors, LLC with notifications on news.